PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Analgesics with anti-emetics
Presentation Product Chemical substance Chapter Items dispensed
Migraleve Pink tablets
0407041A0BBABAG
Migraleve Analgesics with anti-emetics Central Nervous System 12,640
Migraleve tablets
0407041A0BBAAAA
Migraleve Analgesics with anti-emetics Central Nervous System 10,183
Paracetamol 500mg / Metoclopramide 5mg tablets
0407041A0AAADAD
Analgesics with anti-emetics Analgesics with anti-emetics Central Nervous System 1,007
Aspirin 900mg / Metoclopramide 10mg oral pdr sach sugar free
0407041A0AAAJAJ
Analgesics with anti-emetics Analgesics with anti-emetics Central Nervous System 651
MigraMax oral powder sachets
0407041A0BIAAAJ
MigraMax Analgesics with anti-emetics Central Nervous System 563
Paracetamol 500mg / Metoclopramide 5mg efferv pdr sach SF
0407041A0AAACAC
Analgesics with anti-emetics Analgesics with anti-emetics Central Nervous System 548
Paramax sachets
0407041A0BDAAAC
Paramax Analgesics with anti-emetics Central Nervous System 306
Paramax tablets
0407041A0BDABAD
Paramax Analgesics with anti-emetics Central Nervous System 191
Generic Migraleve Pink tablets
0407041A0AAAGAG
Analgesics with anti-emetics Analgesics with anti-emetics Central Nervous System 1
Generic Migraleve tablets
0407041A0AAAAAA
Analgesics with anti-emetics Analgesics with anti-emetics Central Nervous System 1
Domperamol tablets
0407041A0BHAAAI
Domperamol Analgesics with anti-emetics Central Nervous System No data available
Paracetamol 500mg / Domperidone 10mg tablets
0407041A0AAAIAI
Analgesics with anti-emetics Analgesics with anti-emetics Central Nervous System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.